Suppr超能文献

与美国白人相比,非裔美国人的结直肠癌前病变表现出免疫抑制特征。

Preinvasive Colorectal Lesions of African Americans Display an Immunosuppressive Signature Compared to Caucasian Americans.

作者信息

Wallace Kristin, Nahhas Georges J, Bookhout Christine, Lewin David N, Paulos Chrystal M, Nikolaishvili-Feinberg Nana, Cohen Stephanie M, Guglietta Silvia, Bakhtiari Ali, Camp E Ramsay, Hill Elizabeth G, Baron John A, Wu Jennifer D, Alekseyenko Alexander V

机构信息

Hollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, SC, United States.

Department of Public Health Sciences, MUSC, Charleston, SC, United States.

出版信息

Front Oncol. 2021 Apr 27;11:659036. doi: 10.3389/fonc.2021.659036. eCollection 2021.

Abstract

BACKGROUND

African Americans (AAs) have higher colorectal cancer (CRC) incidence and mortality rate than Caucasian Americans (CAs). Recent studies suggest that immune responses within CRCs contribute to the disparities. If racially distinct immune signatures are present in the early phases of carcinogenesis, they could be used to develop interventions to prevent or slow disease.

METHODS

We selected a convenience sample of 95 patients (48 CAs, 47 AAs) with preinvasive colorectal adenomas from the surgical pathology laboratory at the Medical University of South Carolina. Using immunofluorescent-conjugated antibodies on tissue slides from the lesions, we quantified specific immune cell populations: mast cells (CD117), Th17 cells (CD4RORC), and NK cell ligand (MICA/B) and inflammatory cytokines, including , and . We compared the mean density counts (MDCs) and density rate ratios (RR) and 95% CI of immune markers between AAs to CAs using negative binomial regression analysis. We adjusted our models for age, sex, clinicopathologic characteristics (histology, location, dysplasia), and batch.

RESULTS

We observed no racial differences in age or sex at the baseline endoscopic exam. AAs compared to CAs had a higher prevalence of proximal adenomas (66% 40%) and a lower prevalence of rectal adenomas (11% 23%) (p =0.04) but no other differences in pathologic characteristics. In age, sex, and batch adjusted models, AAs CAs had lower RRs for cells labeled with IFNγ (RR 0.50 (95% CI 0.32-0.81); p=0.004) and NK cell ligand (RR 0.67 (0.43-1.04); p=0.07). In models adjusted for age, sex, and clinicopathologic variables, AAs had reduced RRs relative to CAs for CD4 (p=0.02), NK cell ligands (p=0.01), Th17 (p=0.005), mast cells (p=0.04) and IFN-γ (p< 0.0001).

CONCLUSIONS

Overall, the lower RRs in AAs CAs suggests reduced effector response capacity and an immunosuppressive ('cold') tumor environment. Our results also highlight the importance of colonic location of adenoma in influencing these differences; the reduced immune responses in AAs relative to CAs may indicate impaired immune surveillance in early carcinogenesis. Future studies are needed to understand the role of risk factors (such as obesity) in influencing differences in immune responses by race.

摘要

背景

非裔美国人(AAs)的结直肠癌(CRC)发病率和死亡率高于白种美国人(CAs)。最近的研究表明,结直肠癌中的免疫反应导致了这种差异。如果在致癌作用的早期阶段存在种族特异性的免疫特征,那么它们可用于开发预防或减缓疾病的干预措施。

方法

我们从南卡罗来纳医科大学外科病理实验室选取了95例患有浸润前结直肠腺瘤的患者作为便利样本(48例CAs,47例AAs)。使用针对病变组织切片的免疫荧光偶联抗体,我们对特定免疫细胞群体进行了定量:肥大细胞(CD117)、Th17细胞(CD4RORC)、NK细胞配体(MICA/B)以及炎症细胞因子,包括 ,和 。我们使用负二项回归分析比较了AAs与CAs之间免疫标志物的平均密度计数(MDCs)、密度率比(RR)和95%置信区间。我们对模型进行了年龄、性别、临床病理特征(组织学、位置、发育异常)和批次的调整。

结果

在基线内镜检查时,我们未观察到年龄或性别方面的种族差异。与CAs相比,AAs近端腺瘤的患病率更高(66% 对40%),直肠腺瘤的患病率更低(11% 对23%)(p = 0.04),但在病理特征方面没有其他差异。在年龄、性别和批次调整的模型中,AAs与CAs相比,IFNγ标记细胞的RR较低(RR 0.50(95% CI 0.32 - 0.81);p = 0.004),NK细胞配体的RR较低(RR 0.67(0.43 - 1.04);p = 0.07)。在针对年龄、性别和临床病理变量调整的模型中,AAs相对于CAs,CD4(p = 0.02)、NK细胞配体(p = 0.01)、Th17(p = 0.005)、肥大细胞(p = 0.04)和IFN - γ(p < 0.0001)的RR降低。

结论

总体而言,AAs与CAs相比RR较低表明效应器反应能力降低以及肿瘤环境具有免疫抑制性(“冷”)。我们的结果还突出了腺瘤的结肠位置在影响这些差异方面的重要性;AAs相对于CAs免疫反应降低可能表明早期致癌过程中免疫监视受损。未来需要开展研究以了解风险因素(如肥胖)在影响种族间免疫反应差异方面的作用。

相似文献

1
Preinvasive Colorectal Lesions of African Americans Display an Immunosuppressive Signature Compared to Caucasian Americans.
Front Oncol. 2021 Apr 27;11:659036. doi: 10.3389/fonc.2021.659036. eCollection 2021.
2
Immune Responses Vary in Preinvasive Colorectal Lesions by Tumor Location and Histology.
Cancer Prev Res (Phila). 2021 Sep;14(9):885-892. doi: 10.1158/1940-6207.CAPR-20-0592. Epub 2021 Aug 2.
3
Tumor-Infiltrating Lymphocytes and Colorectal Cancer Survival in African American and Caucasian Patients.
Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):755-761. doi: 10.1158/1055-9965.EPI-17-0870. Epub 2018 May 16.
4
Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups.
Dig Dis Sci. 2012 Sep;57(9):2334-9. doi: 10.1007/s10620-012-2195-3. Epub 2012 May 6.
6
Quantitative Multi-Parametric MRI of the Prostate Reveals Racial Differences.
Cancers (Basel). 2024 Oct 16;16(20):3499. doi: 10.3390/cancers16203499.
7
Gut microbiome profiling and colorectal cancer in African Americans and Caucasian Americans.
World J Gastrointest Pathophysiol. 2018 Sep 29;9(2):47-58. doi: 10.4291/wjgp.v9.i2.47.
8
Impact of race-specific screening guideline on the uptake of colorectal cancer screening among young African Americans.
Cancer Med. 2022 Dec;11(24):5013-5024. doi: 10.1002/cam4.4842. Epub 2022 May 29.
9
Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas.
Clin Gastroenterol Hepatol. 2023 Mar;21(3):630-643. doi: 10.1016/j.cgh.2022.12.005. Epub 2022 Dec 20.
10
Acute flavanol consumption improves the cerebral vasodilatory capacity in college-aged African Americans.
Exp Physiol. 2015 Sep;100(9):1030-8. doi: 10.1113/EP085269. Epub 2015 Aug 11.

引用本文的文献

1
The Immune Environment in Colorectal Adenoma: A Systematic Review.
Biomedicines. 2025 Mar 12;13(3):699. doi: 10.3390/biomedicines13030699.
2
Inflammation in cancer: therapeutic opportunities from new insights.
Mol Cancer. 2025 Feb 24;24(1):51. doi: 10.1186/s12943-025-02243-8.
3
Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.
Cancer Causes Control. 2024 Feb;35(2):223-239. doi: 10.1007/s10552-023-01783-y. Epub 2023 Sep 9.
4
Immune response and inflammation in cancer health disparities.
Trends Cancer. 2022 Apr;8(4):316-327. doi: 10.1016/j.trecan.2021.11.010. Epub 2021 Dec 27.

本文引用的文献

1
Metabolic regulation of innate immune cell phenotypes during wound repair and regeneration.
Curr Opin Immunol. 2021 Feb;68:72-82. doi: 10.1016/j.coi.2020.10.012. Epub 2020 Nov 7.
2
The effects of age and systemic metabolism on anti-tumor T cell responses.
Elife. 2020 Nov 10;9:e62420. doi: 10.7554/eLife.62420.
3
Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer.
Gut. 2021 Jun;70(6):1147-1154. doi: 10.1136/gutjnl-2020-321661. Epub 2020 Oct 9.
4
Immune-Related Gene Expression and Cytokine Secretion Is Reduced Among African American Colon Cancer Patients.
Front Oncol. 2020 Sep 2;10:1498. doi: 10.3389/fonc.2020.01498. eCollection 2020.
5
Identification of human CD4 T cell populations with distinct antitumor activity.
Sci Adv. 2020 Jul 1;6(27). doi: 10.1126/sciadv.aba7443. Print 2020 Jul.
6
Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes.
Immunol Rev. 2020 May;295(1):203-219. doi: 10.1111/imr.12849. Epub 2020 Mar 10.
7
Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer.
Cancers (Basel). 2019 Nov 25;11(12):1857. doi: 10.3390/cancers11121857.
8
Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Exp Mol Pathol. 2019 Jun;108:173-182. doi: 10.1016/j.yexmp.2019.04.010. Epub 2019 Apr 17.
9
Racial Disparities in Incidence of Young-Onset Colorectal Cancer and Patient Survival.
Gastroenterology. 2019 Mar;156(4):958-965. doi: 10.1053/j.gastro.2018.11.060. Epub 2018 Dec 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验